← SynDRA
BGP-15
SynDRA canonical compound SYN0040212 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | PARP1 | PARP2 | PARP3 | PARP4 |
| Mechanism of action | PARP inhibitor |
All known targets
- MAPK8; MAPK9; MAPK10
- PARP1
- PARP2
- PARP3
- PARP4
Mechanisms of action (all sources)
Drug classes
Cross-references
Synonyms
- BGP 15
- BGP-15 2HCl
- 3-Pyridinecarboximidamide, N-(2-hydroxy-3-(1-piperidinyl)propoxy)-, hydrochloride (1:2)
- BGP15
- SCHEMBL3067994
- MolPort-039-099-291
- MolPort-027-834-918
- s8370
- AKOS016007888
- AKOS026745444
- SB17119
- CS-6045
- 3-Pyridinecarboximidamide, N-(2-hydroxy-3-(1-piperidinyl)propoxy)-, dihydrochloride
- BGP-15, >
- AS-16983
- TC-162219
- AX8217132
- KB-258115
- HY-100828
- (Z)-N'-(2-hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide dihydrochloride
- BGP-15 free base
- NP-51
- UNII-28ENT76V8K
- SCHEMBL12998977
- SCHEMBL29354224
- EX-A1307
- RCA61137
- NCGC00402337-01
- AC-33042
- N-(2-hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide
- RLN2GTG4YS
- RefChem:119595
- UNII-RLN2GTG4YS
- orb1303958
- SCHEMBL29687972
- BGP-15?
- CHEBI:232856
- GLXC-05825
- CCG-268039
Look up BGP-15 in the interactive SynDRA portal →